For more information about clinical trials at
the Penn Transplant Center, read our answers
to frequently
asked questions.
Studies
Open for Enrollment |
Molecular profiling
and donor and recipient pro-inflammatory
and alloimmune response
Principal
Investigator: Abraham
Shaked, MD, PhD
Sponsored by the National Institutes of Health |
Tissue and serum
bank
Principal Investigator: Kim
Olthoff, MD |
Gene expression
and regenerative pathways in donor livers
Principal
Investigator: Kim
Olthoff, MD
Sponsored by the National Institutes of Health |
Campath-1H and Tacrolimus
followed by Immunosuppression Withdrawal
in Liver Transplantation
Principal
Investigator: Abraham
Shaked, MD, PhD
Sponsored by ITN |
A phase II trial
to assess the safety of immunosuppression
withdrawal in liver transplant recipients
with hepatitis c
Principal Investigator: Abraham
Shaked, MD, PhD
Sponsored by ITN |
Validation of serum
markers for the early detection of hepatocellular
carcinoma (DCP)
Principal Investigator: K.
Rajender Reddy, MD
NCI sponsored |
A to ALL: Adult
to adult living donor liver transplant
cohort study
Principal Investigator: Abraham
Shaked, MD, PhD
Sponsored by the National Institutes of Health |
Clinical, immunologic,
pharmacologic consequences of liver transplantation
in people with HIV infection
Principal
Investigator: Kim
Olthoff, MD
Sponsored by the National Institutes of Health |
Comparative evaluation
of inhibitor treatments in liver allograft
recipients
Principal Investigator: K.
Rajender Reddy, MD |
Comparative safety
and efficacy study of prophylactic Interferon
following liver transplantation for Hepatitis
C
Principal Investigator: K.
Rajender Reddy, MD
Sponsored by the National Institutes of
Health |
Safety and efficacy
study of N-acetylcysteine in the treatment
of acute liver failure not caused by
acetaminophen in adult patients
Principal
Investigator: K.
Rajender Reddy, MD
Sponsored by the National Institutes of Health |
An observational
database of patients who receive orthotopic
liver transplantation (OLT) for Hepatitis
B
Principal Investigator: K.
Rajender Reddy, MD |
 |
Studies Closed to
Enrollment -- Performed Over the Last
Year
|
Comparison of HepeX-BTM,
a mixture of two monoclonal antibodies,
to Hepatitis B immune globulin in patients
who have received hepatic allografts
for treatment of end-stage liver disease
due to Hepatitis B virus infection
Principal
Investigator: K.
Rajender Reddy, MD |
Intravenous Terlipressin
in patients with hepatorenal syndrome
type I
Principal Investigator: K.
Rajender Reddy, MD |
